Abstract
Manohitharajah, S. M., Rahman, A. N., Donnelly, R. J., Deverall, P. B., and Watson, D. A. (1974).Thorax, 29, 639-642. Platelet survival in patients with homograft and prosthetic heart valves. Investigations in the past have demonstrated shortened platelet survival time in patients with prosthetic heart valves. This suggested that platelets contribute to thromboembolism in this group. Homograft valves and the newer models of the Starr-Edwards prosthesis have proved less thrombogenic than those previously employed, but platelet survival studies in patients with these valves are lacking. In this study platelet function, survival, and its relation to haemolysis were determined in 28 patients following mitral valve replacement and in two patients following mitral valvotomy: 14 patients had a frame-mounted homograft aortic valve; 13 patients had a Starr-Edwards prosthesis model 6310 or 6320, and one had a Starr-Edwards prosthesis model 6000. Normal platelet function and survival was found in both the homograft and the Starr valve groups. The patient with the earlier model of the Starr valve (model 6000) had a shortened platelet survival time. The two patients following mitral valvotomy had normal platelet survival. The fact that platelet abnormalities were not demonstrable in our patients with homograft valves and newer Starr-Edwards prostheses may explain the low incidence of thromboembolism in this group. Platelet survival studies are a useful parameter to determine the potential thrombogenic nature of prosthetic valves. Platelet survival time was not influenced by the presence or severity of haemolysis.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- ASTER R. H., JANDL J. H. PLATELET SEQUESTRATION IN MAN. I. METHODS. J Clin Invest. 1964 May;43:843–855. doi: 10.1172/JCI104970. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Akbarian M., Austen G., Yurchak P. M., Scannell J. G. Thromboembolic complications of prosthetic cardiac valves. Circulation. 1968 May;37(5):826–831. doi: 10.1161/01.cir.37.5.826. [DOI] [PubMed] [Google Scholar]
- Donnelly R. J., Rahman A. N., Manohitharajah S. M., Deverall P. B., Watson D. A. Chronic hemolysis following mitral valve replacement. A comparison of the frame-mounted aortic homograft and the composite seat Starr-Edwards prosthesis. Circulation. 1973 Oct;48(4):823–829. doi: 10.1161/01.cir.48.4.823. [DOI] [PubMed] [Google Scholar]
- Grosse-Brockhoff F., Gehrmann G. Mechanical hemolysis in patients with valvular heart disease and valve prosthesis. Am Heart J. 1967 Jul;74(1):137–139. doi: 10.1016/0002-8703(67)90053-1. [DOI] [PubMed] [Google Scholar]
- Harker L. A., Slichter S. J. Studies of platelet and fibrinogen kinetics in patients with prosthetic heart valves. N Engl J Med. 1970 Dec 10;283(24):1302–1305. doi: 10.1056/NEJM197012102832402. [DOI] [PubMed] [Google Scholar]
- Mustard J. F., Jorgensen L., Hovig T., Glynn M. F., Rowsell H. C. Rôle of platelets in thrombosis. Thromb Diath Haemorrh Suppl. 1966;21:131–158. [PubMed] [Google Scholar]
- Starr A., Herr R. H., Wood J. A. Mitral replacement. Review of six years' experience. J Thorac Cardiovasc Surg. 1967 Sep;54(3):333–358. [PubMed] [Google Scholar]
- Sullivan J. M., Harken D. E., Gorlin R. Pharmacologic control of thromboembolic complications of cardiac-valve replacement. A preliminary report. N Engl J Med. 1968 Sep 12;279(11):576–580. doi: 10.1056/NEJM196809122791104. [DOI] [PubMed] [Google Scholar]
- Weily H. S., Genton E. Altered platelet function in patients with prosthetic mitral valves. Effects of sulfinpyrazone therapy. Circulation. 1970 Nov;42(5):967–972. doi: 10.1161/01.cir.42.5.967. [DOI] [PubMed] [Google Scholar]
- Weily H. S., Steele P. P., Genton E. Platelet survival in patients with a Beall valve. Relation to low incidence of thromboembolism. Am J Cardiol. 1972 Aug;30(3):229–231. doi: 10.1016/0002-9149(72)90063-x. [DOI] [PubMed] [Google Scholar]